The QMN Weekly Bulletin
Pharmaceuticals / Regulatory Affairs

U.S., Poland Agree to Exchange GMP Inspection Results

Dec. 6, 2013
A A
The U.S. Food and Drug Administration and Poland’s Główny Inspektorat Farmaceutyczny have agreed to share the results of good manufacturing practice inspections, building on a practice increasingly embraced by regulators around the world.
International Pharmaceutical Regulatory Monitor